Fig. 5From: Establishment of an antibody specific for AMIGO2 improves immunohistochemical evaluation of liver metastases and clinical outcomes in patients with colorectal cancer Comparison of two AMIGO2 antibodies in AMIGO2 expression and survival in CRC patients. Cumulative survival rates were assessed using the Kaplan-Meier plot method. Differences were analyzed using the log-rank test. Overall survival (A) and disease-specific survival (B) are shownBack to article page